Natixis Advisors Significantly Boosts U.S. Bancorp Stake Amid Broader Institutional Portfolio Rebalancing

Natixis Advisors LLC disclosed via recent SEC 13F filings that it increased stakes in several U.S.-listed companies, including Prologis, Medpace, Elevance Health, Brown & Brown, and U.S. Bancorp. The fund raised its Prologis position by 4.8% in the fourth quarter and also added to Medpace by 8.9% and Elevance Health by 9.1%. Natixis increased its Brown & Brown stake by 20.4% and boosted its U.S. Bancorp holding by 190.5% in the fourth quarter. Across these stocks, multiple other institutional investors also shifted positions—some making large additions—highlighting active portfolio rebalancing rather than a single-company story. In each case, the filings indicate substantial institutional ownership overall, reinforcing that these moves are occurring within broadly held, professionally managed equity portfolios.
For Prologis, Natixis Advisors LLC reported it owned 954,485 shares after buying an additional 43,452 shares in the quarter, with the stake valued at about $121.85 million; the article also notes that hedge funds and other institutional investors own 93.50% of Prologis.
For Medpace, the filing details Natixis held 163,360 shares after purchasing 13,412 additional shares, valued at roughly $91.75 million, and the article reports UBS Group AG increased its stake by 32.8% in the fourth quarter to 328,879 shares (about $184.72 million).
For Elevance Health, Natixis ended the period with 267,062 shares after adding 22,267 shares (about $93.62 million), and the article adds that institutional investors own 89.24% of the company’s stock.
For Brown & Brown, beyond Natixis’s purchase, the article highlights insider activity: Director H. Palmer Proctor, Jr. bought 2,000 shares of the company’s stock (described as “in other Brown & Brown news”).
For U.S. Bancorp, Natixis reported owning 1,334,203 shares after buying an additional 874,936 shares, with the position valued at about $71.19 million; the article also states hedge funds and other institutional investors own 77.60% of the bank’s stock.
Publishers
89
Articles
65
Reach
154